AI drug discovery startup Enveda raises $311M, doubling its valuation to $2B
AI drug discovery startup Enveda has reportedly raised $311 million, which doubles its valuation to $2 billion. The funding round was exclusively reported by The Wall Street Journal and subsequently covered by qz.com. This financial milestone was confirmed by the company.
3 articles from 3 outlets covered this story. The underlying claim is sourced from a press release.
What do all outlets agree on?
3 outlets covered “AI drug discovery startup Enveda raises $311M, doubling its valuation to $2B”. All of them report the following:
- Enveda is an AI drug discovery startup
- Enveda raised $311 million
- Enveda's valuation doubled
- Enveda's new valuation is $2 billion
Which outlets covered this?
All 3 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.
optimist2
pragmatist1